Given the pathogenetic and therapeutic implications associated with the development and progressive advancement of α-synuclein lesions in PD, it is not surprising that a variety of in vitro and in vivo experimental systems were developed to mimic cell-to-cell protein transfer and spreading of α-synuclein pathology within the brain and between the brain and peripheral tissues. This evidence concerns the gene SNCA and Parkinson disease.